SCIENTISTS ENGAGING + ENLIGHTENING SCIENTISTS
Drug Discovery News (DDN) is the latest addition to LabX Media’s Science Technology Group.
DDN provides engaging stories about scientific breakthroughs to help life science researchers develop diagnostic and therapeutic approaches for improving human health.
EXPLORING DRUG DISCOVERY AND DEVELOPMENT
DDN brings together a large group of decision makers from pharma, biotech, non-profit, academic, clinical, and government labs. Our readers span research fields from analytical chemistry to toxicology, and from basic through translational, preclinical, and clinical research stages.
35,000+
Print subscribers
60%
Of the audience works in commercial or clinical labs
58,067
Newsletter subscribers
78,614
3rd party subscribers
95%
Of DDN subscribers are involved in some aspect of the purchasing decisions for new products and technologies in the lab – based on data from a 2023 Reader Survey
TEAM UP WITH DRUG DISCOVERY NEWS
Our editorial and content creation teams are made up of scientists, so we know how your customers think and what they need. We will partner with you to bring your message directly to our broad audience of basic, translational, preclinical, and clinical research scientists.